Atlas Trials

Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.

Clinical trial NCT02017444 · COMPLETED

Trial details

NCT number
NCT02017444
Sponsor
University of Birmingham
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Intracranial Hypertension
Start date
2014-04-25
Primary completion
2016-12-19
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.